Other findings have indicated that vorinostat crosses the blood–brain barrier.20–22 In the present study, induction of FPGS expression and the concomitant decrease in DHFR expression by vorinostat would enhance the synergism of the MTX and vorinostat combination in lymphoma cell lines. This evidence concerns the gene DHFR and lymphoma.